{"id":"sodium-hyaluronate-eye-drops","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Eye irritation or stinging"},{"rate":null,"effect":"Allergic reaction (rare)"}]},"_chembl":{"chemblId":"CHEMBL4594244","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sodium hyaluronate is a naturally occurring polysaccharide that acts as a humectant, binding water molecules to the corneal and conjunctival epithelium. This hydrophilic polymer creates a viscous layer that protects the eye surface, reduces evaporation of tears, and alleviates symptoms of dry eye by maintaining corneal hydration and reducing mechanical irritation.","oneSentence":"Sodium hyaluronate forms a protective, lubricating film on the ocular surface to retain moisture and reduce friction.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:32.877Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome / keratoconjunctivitis sicca"},{"name":"Ocular surface irritation and discomfort"}]},"trialDetails":[{"nctId":"NCT07451184","phase":"PHASE4","title":"Comparison of Ocular Lubricants in People With Symptoms of Dry Eye","status":"RECRUITING","sponsor":"University of Waterloo","startDate":"2026-02-23","conditions":"Dry Eye Symptoms","enrollment":100},{"nctId":"NCT04704531","phase":"PHASE2","title":"Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2022-01-03","conditions":"Dry Eye","enrollment":141},{"nctId":"NCT07291089","phase":"PHASE4","title":"Iris Vascular Area Density-Based Preoperative Pain-Risk Screening and Intervention in Second-Eye Cataract Surgery","status":"COMPLETED","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-02-23","conditions":"Age Related Cataract, Pain Management During Cataract Surgery","enrollment":126},{"nctId":"NCT04702776","phase":"PHASE4","title":"Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2021-12-09","conditions":"Dry Eye","enrollment":182},{"nctId":"NCT07412860","phase":"NA","title":"Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED","status":"RECRUITING","sponsor":"FB Vision S.p.A","startDate":"2025-03-26","conditions":"Dry Eye Syndromes, Dry Eye Disease (DED)","enrollment":74},{"nctId":"NCT05865457","phase":"NA","title":"Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease","status":"RECRUITING","sponsor":"TRB Chemedica International SA","startDate":"2025-09-25","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT05865379","phase":"NA","title":"Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease","status":"RECRUITING","sponsor":"TRB Chemedica International SA","startDate":"2026-03","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT01684852","phase":"","title":"Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2012-05","conditions":"Dry Eye Syndromes","enrollment":64},{"nctId":"NCT05965778","phase":"NA","title":"Performance and Safety of T2769 in DED","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2023-10-02","conditions":"Dry Eye","enrollment":251},{"nctId":"NCT06163989","phase":"NA","title":"Protecting the Eyes of Gamers With Lubricating Eyedrops","status":"RECRUITING","sponsor":"Aston University","startDate":"2024-09-01","conditions":"Dry Eye Syndromes, Computer Vision Syndrome","enrollment":28},{"nctId":"NCT05411367","phase":"PHASE3","title":"A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye","status":"COMPLETED","sponsor":"Seikagaku Corporation","startDate":"2022-07-28","conditions":"Dry Eye Disease","enrollment":232},{"nctId":"NCT03697876","phase":"PHASE1","title":"Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-08-20","conditions":"Dry Eye Syndromes","enrollment":32},{"nctId":"NCT05777798","phase":"","title":"Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye Discomfort","status":"COMPLETED","sponsor":"SIFI SpA","startDate":"2023-03-14","conditions":"Ocular Dryness","enrollment":28},{"nctId":"NCT06375499","phase":"NA","title":"Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2024-09-17","conditions":"Dry Eye Syndrome","enrollment":74},{"nctId":"NCT06981104","phase":"NA","title":"Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-11-18","conditions":"Dry Eye Disease (DED), Asthenopia","enrollment":60},{"nctId":"NCT07007702","phase":"","title":"Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2025-01-27","conditions":"Dry Eye Disease (DED)","enrollment":30},{"nctId":"NCT07185854","phase":"NA","title":"Medical vs Acupuncture for Dry Eye","status":"COMPLETED","sponsor":"Nadide Koca","startDate":"2024-01-15","conditions":"Dry Eye, Acupuncture","enrollment":90},{"nctId":"NCT06903884","phase":"PHASE3","title":"3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-12-30","conditions":"Vernal Keratoconjunctivitis","enrollment":94},{"nctId":"NCT07089511","phase":"NA","title":"Cord Blood Platelet Poor Plasma Eye Drops","status":"RECRUITING","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2025-03-11","conditions":"Dry Eye","enrollment":100},{"nctId":"NCT06936462","phase":"NA","title":"Potential Role of Ocular Surface Microbiome in Dry Eye: Microbial Interactions and Symptom Alleviation","status":"COMPLETED","sponsor":"Hallym University Kangnam Sacred Heart Hospital","startDate":"2020-01-20","conditions":"Dry Eye Syndrome (DES)","enrollment":50},{"nctId":"NCT07064187","phase":"PHASE4","title":"Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery","status":"COMPLETED","sponsor":"Nguyen Viet Giap","startDate":"2022-06-15","conditions":"Ocular Discomfort","enrollment":100},{"nctId":"NCT07097922","phase":"NA","title":"Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients With Dry Eye After LASIK","status":"NOT_YET_RECRUITING","sponsor":"He Eye Hospital","startDate":"2025-08-01","conditions":"Dry Eye","enrollment":140},{"nctId":"NCT05682547","phase":"NA","title":"Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye","status":"COMPLETED","sponsor":"He Eye Hospital","startDate":"2022-12-01","conditions":"Diabetic Eye Problems","enrollment":99},{"nctId":"NCT06985875","phase":"PHASE3","title":"Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%","status":"NOT_YET_RECRUITING","sponsor":"Avizor SA","startDate":"2025-07","conditions":"Eye Dryness","enrollment":79},{"nctId":"NCT06803654","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2025-05-22","conditions":"Ocular Redness","enrollment":578},{"nctId":"NCT06818487","phase":"NA","title":"Ganyan-1 in Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2025-07-01","conditions":"Dry Eye, TCM","enrollment":219},{"nctId":"NCT05773963","phase":"NA","title":"A Post-market Study to Evaluate the Effects of Sodium Hyaluronate Based Eye Drops in Patients Affected by Dry Eye Disease","status":"TERMINATED","sponsor":"Montefarmaco OTC SpA","startDate":"2022-02-24","conditions":"Opthalomology/Dry Eye","enrollment":80},{"nctId":"NCT03368404","phase":"NA","title":"A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye","status":"COMPLETED","sponsor":"Laboratoire Chauvin","startDate":"2017-11-09","conditions":"Dry Eye","enrollment":92},{"nctId":"NCT06901895","phase":"NA","title":"Comparing Effect of Hyaluronic Acid and Lipid Coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":"Dry Eye","enrollment":64},{"nctId":"NCT06163105","phase":"NA","title":"The Effect of Gland Expression on the Regeneration of Meibomian Gland","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2024-10-03","conditions":"Meibomian Gland Dysfunction","enrollment":64},{"nctId":"NCT06860659","phase":"PHASE4","title":"Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye","status":"ENROLLING_BY_INVITATION","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2024-09-01","conditions":"Dry Eye Disease (DED), Tear Break-Up Time, Tear Disorder","enrollment":84},{"nctId":"NCT06370585","phase":"PHASE1","title":"Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2024-05-16","conditions":"Dry Eye Disease, Ocular Surface Disease","enrollment":36},{"nctId":"NCT05874453","phase":"NA","title":"Effect of Evidence-Based Eye Care Protocol in Intensive Care Units","status":"UNKNOWN","sponsor":"TC Erciyes University","startDate":"2024-03-15","conditions":"Ocular Complications, Eye Protocol","enrollment":40},{"nctId":"NCT06851364","phase":"PHASE2","title":"Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants","status":"COMPLETED","sponsor":"International Islamic University Malaysia","startDate":"2022-10-30","conditions":"Dry Eye","enrollment":45},{"nctId":"NCT06852105","phase":"NA","title":"Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK","status":"NOT_YET_RECRUITING","sponsor":"He Eye Hospital","startDate":"2025-02-28","conditions":"Dry Eye, Tear Break-Up Time","enrollment":76},{"nctId":"NCT02510235","phase":"NA","title":"Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2015-03-09","conditions":"Dry Eye Syndrome, Tear Film Insufficiency","enrollment":56},{"nctId":"NCT05379855","phase":"NA","title":"A-eyedrops on Ocular Alignment and Binocular Vision","status":"RECRUITING","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-03-02","conditions":"Exotropia, Exophoria, Myopia","enrollment":339},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT05931861","phase":"NA","title":"Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2023-08-15","conditions":"Dry Eye","enrollment":34},{"nctId":"NCT06798025","phase":"NA","title":"Three Different Modalities for Treatment of Inflammatory Punctal Stenosis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-07-20","conditions":"Modalities, Treatment, Inflammatory Punctal Stenosis","enrollment":60},{"nctId":"NCT06731725","phase":"NA","title":"Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye","status":"COMPLETED","sponsor":"i+Med S.Coop.","startDate":"2021-02-17","conditions":"Dry Eye, Dry Eye Syndrome (DES)","enrollment":20},{"nctId":"NCT03031327","phase":"NA","title":"Safety and Efficacy of 2 Concentrations of Lubricin vs Sodium Hyaluronate in Ocular Discomfort After Refractive Surgery.","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2017-06-17","conditions":"Ocular Discomfort","enrollment":30},{"nctId":"NCT06696625","phase":"NA","title":"Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye","status":"RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2021-07-01","conditions":"Dry Eye Disease","enrollment":256},{"nctId":"NCT06686368","phase":"PHASE4","title":"Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"I-MED Pharma","startDate":"2024-11-15","conditions":"Evaporative Dry Eye Disease","enrollment":60},{"nctId":"NCT06656403","phase":"NA","title":"Effect of Artificial Tears on Ocular Biometry Parameters","status":"NOT_YET_RECRUITING","sponsor":"He Eye Hospital","startDate":"2024-10-30","conditions":"Dry Eye Disease, Tear Film","enrollment":100},{"nctId":"NCT02507934","phase":"NA","title":"Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2015-06-26","conditions":"Dry Eye Syndrome","enrollment":40},{"nctId":"NCT05290727","phase":"NA","title":"Efficacy of \"Aquoral Lipo\" Artificial Tears in Contact Lens Wearers With Discomfort","status":"COMPLETED","sponsor":"Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA","startDate":"2022-03-01","conditions":"Contact Lens Complication","enrollment":41},{"nctId":"NCT06614348","phase":"PHASE2","title":"Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-10-08","conditions":"Age Related Cataract, Pain Management During Cataract Surgery","enrollment":70},{"nctId":"NCT04673643","phase":"PHASE2","title":"Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease","status":"RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2021-07-01","conditions":"Dry Eye Disease","enrollment":128},{"nctId":"NCT06573606","phase":"","title":"Ophthalmic Solution in Diabetic Corneal Alteration","status":"COMPLETED","sponsor":"D&V FARMA srl","startDate":"2021-09-01","conditions":"Dry Eye Disease (DED)","enrollment":20},{"nctId":"NCT06544447","phase":"PHASE1, PHASE2","title":"Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction","status":"RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2021-06-01","conditions":"Dry Eye","enrollment":135},{"nctId":"NCT06189456","phase":"NA","title":"Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%","status":"UNKNOWN","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2023-06-21","conditions":"Dry Eye Syndrome (DES)","enrollment":100},{"nctId":"NCT06517667","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye","status":"COMPLETED","sponsor":"University of Seville","startDate":"2023-11-01","conditions":"Dry Eye","enrollment":30},{"nctId":"NCT06478134","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease","status":"COMPLETED","sponsor":"University of Seville","startDate":"2023-07-01","conditions":"Dry Eye","enrollment":124},{"nctId":"NCT02975102","phase":"NA","title":"A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye","status":"COMPLETED","sponsor":"Laboratoire Chauvin","startDate":"2017-03-01","conditions":"Dry Eye","enrollment":87},{"nctId":"NCT06461975","phase":"PHASE3","title":"Effect of Benoxinate Hydrochloride Eye Drops on The Premature Infant Pain Profile Score During Retinopathy of Prematurity Screening","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-01-01","conditions":"Retinopathy of Prematurity","enrollment":88},{"nctId":"NCT04421300","phase":"NA","title":"A Randomized Study of Smile Exercise for Dry Eye","status":"COMPLETED","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2020-07-02","conditions":"Dry Eye, Keratoconjunctivitis Sicca, Eye Diseases","enrollment":299},{"nctId":"NCT04704518","phase":"PHASE4","title":"Phase IV Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive Keratectomy (PRK)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2022-09-03","conditions":"Photorefractive Keratectomy, Corneal De-epithelialization","enrollment":88},{"nctId":"NCT05823961","phase":"NA","title":"PMCF Study to Evaluate Performance and Safety of \"CLHA-based Eyedrops\" Used to Improve Lacrimal Abnormalities","status":"COMPLETED","sponsor":"C.O.C. Farmaceutici S.r.l.","startDate":"2022-06-10","conditions":"Dry Eye Disease, Dry Eye, Kerato Conjunctivitis Sicca","enrollment":80},{"nctId":"NCT05807360","phase":"NA","title":"PMCF Study to Evaluate Performance and Safety of \"Hyaluronic Acid (HA)-Based Eyedrops\" Used to Relieve Dry Eye Symptoms","status":"COMPLETED","sponsor":"C.O.C. Farmaceutici S.r.l.","startDate":"2022-06-24","conditions":"Dry Eye, Dry Eye Disease, Kerato Conjunctivitis Sicca","enrollment":160},{"nctId":"NCT06317922","phase":"NA","title":"Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF Injections","status":"RECRUITING","sponsor":"Francesco Bandello","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":60},{"nctId":"NCT05159284","phase":"PHASE4","title":"Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction","status":"RECRUITING","sponsor":"Laboratorios Thea, Spain","startDate":"2021-11-09","conditions":"Dry Eye, Meibomian Gland Dysfunction","enrollment":54},{"nctId":"NCT06209879","phase":"PHASE4","title":"Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT06243991","phase":"","title":"The Effect Of High And Low Molecular Weight Sodium Hyaluronic Acid Eye Drops After Crosslinking","status":"COMPLETED","sponsor":"Marmara University","startDate":"2021-03-01","conditions":"Keratoconus","enrollment":63},{"nctId":"NCT05778942","phase":"","title":"Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness","status":"COMPLETED","sponsor":"SIFI SpA","startDate":"2023-02-23","conditions":"Dry Eye Syndromes","enrollment":35},{"nctId":"NCT06221345","phase":"PHASE4","title":"Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-07","conditions":"Dry Eye Disease, Cataract","enrollment":70},{"nctId":"NCT06122428","phase":"","title":"Efficacy of Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry Eye Disease","status":"COMPLETED","sponsor":"University of Naples","startDate":"2022-02-08","conditions":"Dry Eye Disease","enrollment":16},{"nctId":"NCT03874429","phase":"NA","title":"Efficacy of T2259 in DED","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2019-04-24","conditions":"Dry Eye Syndromes","enrollment":101},{"nctId":"NCT06034626","phase":"PHASE3","title":"Therapeutic Effectiveness of Different Machines in Intense Pulsed Light Treatment of Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-11-03","conditions":"MGD-Meibomian Gland Dysfunction","enrollment":216},{"nctId":"NCT04465071","phase":"NA","title":"Lubricating Eye Drops After Routine Cataract Surgery","status":"COMPLETED","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2020-02-24","conditions":"Dry Eye, Cataract","enrollment":79},{"nctId":"NCT05618730","phase":"PHASE1","title":"Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B","status":"UNKNOWN","sponsor":"Eximore Ltd.","startDate":"2022-09-29","conditions":"Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation","enrollment":20},{"nctId":"NCT05990712","phase":"PHASE4","title":"The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers","status":"UNKNOWN","sponsor":"Uptown Eye Specialists","startDate":"2023-09-01","conditions":"Dry Eye, Dry Eye Syndromes, Cataract","enrollment":68},{"nctId":"NCT05733741","phase":"PHASE4","title":"Preservative-free Topical Anesthetics for Post-PRK Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2023-01-30","conditions":"Myopia","enrollment":70},{"nctId":"NCT05771194","phase":"PHASE4","title":"Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients","status":"COMPLETED","sponsor":"Tianjin Medical University Eye Hospital","startDate":"2021-02-01","conditions":"Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid","enrollment":40},{"nctId":"NCT05724056","phase":"NA","title":"Idroflog® for Treatment of Dry Eye Disease (IDROFLOG)","status":"UNKNOWN","sponsor":"Alfa Intes Industria Terapeutica Splendore s.r.l.","startDate":"2023-03-01","conditions":"Dry Eye Disease","enrollment":130},{"nctId":"NCT04980144","phase":"NA","title":"Diquafosol Ophthalmic Solution for Dry Eye Symptoms","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-03-03","conditions":"Diabetic Eye Problems","enrollment":101},{"nctId":"NCT03803748","phase":"NA","title":"A Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi®","status":"COMPLETED","sponsor":"SIFI SpA","startDate":"2019-07-17","conditions":"Dry Eye Syndromes","enrollment":96},{"nctId":"NCT04668131","phase":"NA","title":"Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2020-09-22","conditions":"Dry Eye","enrollment":20},{"nctId":"NCT03186755","phase":"PHASE4","title":"Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis","status":"UNKNOWN","sponsor":"Michael Marchand, MD","startDate":"2017-06-11","conditions":"Conjunctivitis, Allergic, Conjunctivitis, Vernal","enrollment":42},{"nctId":"NCT05356728","phase":"NA","title":"Comparison of Two Types of Artificial Tears","status":"UNKNOWN","sponsor":"The Norwegian Dry Eye Clinic","startDate":"2022-03-11","conditions":"Dry Eye Disease","enrollment":96},{"nctId":"NCT05429229","phase":"PHASE2","title":"Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Adolfo Daniel Rodriguez-Carrizalez","startDate":"2021-11-01","conditions":"Dry Eye Syndromes, Diabetic Retinopathy, Oxidative Stress","enrollment":78},{"nctId":"NCT04127851","phase":"PHASE4","title":"Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients","status":"COMPLETED","sponsor":"Taejoon Pharmaceutical Co., Ltd.","startDate":"2019-11-12","conditions":"Dry Eye, Dry Eye Syndromes","enrollment":438},{"nctId":"NCT03803722","phase":"NA","title":"To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance","status":"TERMINATED","sponsor":"SIFI SpA","startDate":"2019-07-08","conditions":"Dry Eye Syndrome","enrollment":21},{"nctId":"NCT05313425","phase":"","title":"Effect of Ectoine After Photorefractive Keratectomy (PRK).","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2022-01-01","conditions":"Photorefractive Keratectomy, Corneal Haze","enrollment":15},{"nctId":"NCT05131152","phase":"NA","title":"Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye","status":"UNKNOWN","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2021-12-01","conditions":"Dry Eye","enrollment":100},{"nctId":"NCT01738243","phase":"PHASE4","title":"Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2013-12","conditions":"Thyroid Eye Disease","enrollment":2},{"nctId":"NCT05053789","phase":"NA","title":"Efficacy of Different Treatment Regimens With Chitosan-N- Acetylcysteine in Moderate-to-severe Dry Eye Disease","status":"TERMINATED","sponsor":"Vienna Institute for Research in Ocular Surgery","startDate":"2021-05-12","conditions":"Eye Diseases","enrollment":48},{"nctId":"NCT05049629","phase":"NA","title":"Effect of Chitosan-N-Acetylcysteine on IOL-power Prior to Cataract Surgery","status":"TERMINATED","sponsor":"Vienna Institute for Research in Ocular Surgery","startDate":"2021-05-12","conditions":"Eye Diseases","enrollment":30},{"nctId":"NCT02257957","phase":"PHASE3","title":"Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye","status":"COMPLETED","sponsor":"Universidad Nacional de Colombia","startDate":"2014-11-30","conditions":"Dry Eye, Sjogren Syndrome","enrollment":30},{"nctId":"NCT05006898","phase":"PHASE1","title":"Compound to Control Presbyopia Symptoms","status":"COMPLETED","sponsor":"Optall Vision","startDate":"2020-06-01","conditions":"Presbyopia","enrollment":11},{"nctId":"NCT05001243","phase":"PHASE1","title":"Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients","status":"UNKNOWN","sponsor":"Optall Vision","startDate":"2021-08-10","conditions":"Presbyopia","enrollment":11},{"nctId":"NCT05002036","phase":"PHASE4","title":"Management of Dry Eye Disease After Cataract Surgery With Topical Hyaluronic Acid and Gingko Biloba","status":"COMPLETED","sponsor":"University of Milan","startDate":"2021-02-01","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT04081610","phase":"PHASE1","title":"Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2019-09-09","conditions":"Dry Eye","enrollment":34},{"nctId":"NCT02804191","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis","status":"COMPLETED","sponsor":"Ocuwize LTD","startDate":"2016-07","conditions":"Conjunctivochalasis","enrollment":62},{"nctId":"NCT03319420","phase":"PHASE4","title":"Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome","status":"COMPLETED","sponsor":"Ocuwize LTD","startDate":"2018-03-29","conditions":"Dry Eye Due to Sjögren's Syndrome","enrollment":60},{"nctId":"NCT04711642","phase":"PHASE3","title":"Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery","status":"UNKNOWN","sponsor":"Fundación Oftalmológica Los Andes","startDate":"2021-01-15","conditions":"Dry Eye Disease, Dry Eye Syndrome, Evaporative Dry Eye","enrollment":100},{"nctId":"NCT04706455","phase":"NA","title":"Effect of Artificial Tears on the Parameters of the Eye and Its Impact on IOL Power Calculation for Cataract Surgery","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2020-12-01","conditions":"Cataract Senile, Dry Eye","enrollment":60},{"nctId":"NCT04667819","phase":"NA","title":"Wireless Micropump in Dry Eye Patients","status":"UNKNOWN","sponsor":"Tianjin Eye Hospital","startDate":"2020-12","conditions":"Dry Eye","enrollment":20},{"nctId":"NCT04624035","phase":"NA","title":"Implantable Phakic Lens (IPCL) VS Implantable Collamer Lens","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-10-10","conditions":"Myopia","enrollment":60},{"nctId":"NCT03640351","phase":"NA","title":"Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2017-08-15","conditions":"Dry Eye, Cataract Surgery","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":76,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["artificial tears"],"phase":"marketed","status":"active","brandName":"Sodium hyaluronate eye drops","genericName":"Sodium hyaluronate eye drops","companyName":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","companyId":"guang-anmen-hospital-of-china-academy-of-chinese-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium hyaluronate forms a protective, lubricating film on the ocular surface to retain moisture and reduce friction. Used for Dry eye syndrome / keratoconjunctivitis sicca, Ocular surface irritation and discomfort.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}